Press Releases September 4, 2026 06:45 AM

Brookfield Announces Intention to Redeem its Class A Preference Shares, Series 51 and 52

Brookfield Corporation announces the redemption of Series 51 and Series 52 Class A Preference Shares effective November 1, 2026.

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
BN

Brookfield Corporation declared its intention to redeem all outstanding Cumulative Redeemable Class A Preference Shares, Series 51 and Series 52, at specified redemption prices plus accrued dividends by November 1, 2026. This move affects shareholders in these preferred share series, with dividends paid through October 30, 2026. Brookfield is a global investment firm with operations in asset management, infrastructure, energy, private equity, and real estate, listed on NYSE and TSX.

Brookfield Announces Intention to Redeem its Class A Preference Shares, Series 51 and 52
BN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Brookfield to redeem all Series 51 and Series 52 Cumulative Redeemable Class A Preference Shares for cash on November 1, 2026.
  • Redemption price for Series 51 Shares set at $22.44 plus accrued dividends; Series 52 Shares at $22.00 plus previously declared final dividend.
  • Brookfield is a global investment firm with core businesses in asset management, wealth solutions, and operating businesses across infrastructure, energy, private equity, and real estate.

All amounts in Canadian dollars unless otherwise stated.

BROOKFIELD, NEWS, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Brookfield Corporation (“Brookfield”) (NYSE: BN, TSX: BN) today announced that it intends to redeem all of its Cumulative Redeemable Class A Preference Shares, Series 51 (the “Series 51 Shares”) (TSX: BN.PF.K) and all of its Cumulative Redeemable Class A Preference Shares, Series 52 (the “Series 52 Shares”) (TSX: BN.PF.L) for cash on November 1, 2026 (the “Redemption Date”). The redemption price for each Series 51 Share will be $22.44, together with all accrued and unpaid dividends up to but excluding the Redemption Date. The redemption price for each Series 52 Share will be $22.00. Holders of the Series 52 Shares of record as of October 15, 2026 will also receive the previously declared final quarterly dividend of $0.151250 per Series 52 Share, payable on October 30, 2026.

About Brookfield Corporation

Brookfield Corporation is a leading global investment firm focused on building long-term wealth for institutions and individuals around the world. We have three core businesses: Asset Management, Wealth Solutions, and our Operating Businesses which are in infrastructure, energy, private equity, and real estate.

We have a track record of delivering 15%+ annualized returns to shareholders for over 30 years, supported by our investment and operational experience. Our conservatively managed balance sheet, extensive operational experience, and global sourcing networks allow us to consistently access unique opportunities. At the center of our success is the Brookfield Ecosystem, which is based on the fundamental principle that each group within Brookfield benefits from being part of the broader organization. Brookfield Corporation is publicly traded in New York and Toronto (NYSE: BN, TSX: BN).

For more information, please visit our website at www.bn.brookfield.com or contact:

Media:
Kerrie McHugh
Tel: (212) 618-3469
Email: kerrie.mchugh@brookfield.com Investor Relations:
Katie Battaglia
Tel: (416) 359-8544
Email: katie.battaglia@brookfield.com

Risks

  • Potential liquidity impact for holders of the redeemed preference shares as they receive cash in exchange for shares.
  • Market risk if redemption results in a change in Brookfield's capital structure or alters investor perception of its preferred shares.
  • Economic sectors impacted include financial markets due to changes in preferred equity instruments and related investment and real estate sectors linked to Brookfield's operational areas.

More from Press Releases

Clearmind Medicine Signs Definitive Agreement to Acquire 51% Stake in Wireless Charging Company for Automated Parking and Robotaxis Sep 4, 2026 Glass House Brands to Participate in Upcoming September Investor Conferences Sep 4, 2026 Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences Sep 4, 2026 VERAXA Biotech Appoints Raju Willener as Chief Financial Officer Sep 4, 2026 INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives Sep 4, 2026